Genprex, Inc. (GNPX)

NasdaqCM Currently down 147.20 (-98.79%) in today's trading session

Track congressional stock trades in Genprex, Inc. (GNPX). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Genprex, Inc. is currently trading at $1.80, positioned at 0% of its 52-week range ($1.71 – $55.00). View which politicians have recently bought or sold GNPX and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$1.80
24h Change
-147.20 (-98.79%)
52 Week Range
$1.71$55.00
View on NASDAQ

Genprex, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for GNPX

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$2.94M

Volume

154.9K

Beta

-0.72

P/E Ratio

Fundamentals

EPS

$-1261.62

Div. Yield

Open

$1.84

Day Range

$1.79 — $1.87

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Ryan Confer
IPO Date
2018-03-29

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company i...

Earnings

Next Report

Q1 2026

3 Jun

EPS Est.

Rev. Est.

Days Until

65

Recent Quarters

Q4 202527 Mar
EPS
Q3 202514 Nov
EPS$-5.00
Beat 60.0%
Q2 202514 Aug
EPS$-8.50
Beat 59.5%
Q1 202512 May
EPS$-0.26
Beat 68.3%
Q1 20257 Apr
EPS$-1.15
Miss 40.2%
Q3 202413 Nov
EPS$-1.23
Miss 8.8%
Q2 20249 Aug
EPS$-3.00
Miss 30.4%
Q1 202415 May
EPS$-3.69
Miss 45.3%
Q4 202329 Mar
EPS$-3.96
Miss 0.8%
Q3 202314 Nov
EPS$-5.20
Miss 4627.3%
Q2 202321 Aug
EPS$-6.00
Miss 25.0%
Q1 202322 May
EPS$-7.60
Miss 58.3%
Q4 202231 Mar
EPS$-6.00
Miss 15.4%
Q3 202214 Nov
EPS$-5.20
Miss 4233.3%
Q2 202212 Aug
EPS$-4.40
Miss 10.0%
Q1 202213 May
EPS$-4.80
Miss 33.3%
Q4 202130 Mar
EPS$-4.80
Miss 5233.3%
Q3 202115 Nov
EPS$-2.80
Q2 202113 Aug
EPS$-3.20
Miss 2361.5%
Q1 202117 May
EPS$-5.60
Miss 4566.7%
Q4 202026 Mar
EPS$-5.60
Miss 1900.0%
Q3 202012 Nov
EPS$-2.80
Miss 1233.3%
Q2 202011 Aug
EPS$-4.80
Beat 36.8%
Q1 202014 May
EPS$-8.00
Miss 6566.7%
Q4 201930 Mar
EPS$-5.60
Q3 201914 Nov
EPS$-6.00
Beat 31.8%
Q2 201913 Aug
EPS$-9.60
Miss 14.3%
Q1 201915 May
EPS$-5.60
Beat 39.1%
Q1 20191 Apr
EPS$-9.20
Miss 27.8%
Q3 201814 Nov
EPS$-0.15
Miss 15.4%
Q2 201814 Aug
EPS$-17.95
Q1 201815 May
EPS$-2.36
Q4 201729 Mar
EPS$-2.32
Q3 201727 Nov
EPS$-2.46
Q1 201730 Jun
EPS$-4.12
Q4 201631 Mar
EPS$-2.64
Q3 201631 Dec
EPS$-6.16
Q2 201630 Sept
EPS$-13.45
Q1 201630 Jun
EPS$-38.55
Q4 201531 Mar
EPS$-6.33

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LGIH

LGI Homes, Inc.

17
$37.69-0.04 (-0.12%)
Consumer Cyclical
Held by same politician
1 politician
View Stock

HOG

Harley-Davidson, Inc.

17
$19.39-0.08 (-0.41%)
Consumer Cyclical
Held by same politician
1 politician
View Stock

SMPL

The Simply Good Foods Company

17
$14.54+0.19 (+1.32%)
Consumer Defensive
Held by same politician
1 politician
View Stock
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.